New findings emerging from the research team at Queen’s University Belfast have identified a cellular process which can be exploited in order to kill BRAF mutant colon cancer cells, a particularly aggressive subgroup of colon cancers. These cancers are not only extremely aggressive but they do not respond well to conventional cancer treatments.
The QUB team behind the discovery describe it as a “ground-breaking therapeutic process that can target and kill bowel cancer cells”. The treatment will be a key tool in tackling the most aggressive form of the illness which conventional treatments have little or no impact on. The revolutionary technique may improve survival rates for colon cancer patients globally.
Professor Sandra Van Schaeybroeck, remarked: “This research is good news for bowel cancer patients as further clinical trials investigating the effect of such agents could improve the survival outcome of patients in Northern Ireland and beyond.”
Congratulations to all researchers involved!
Here is some digital press coverage of this story: